Demographic and clinical characteristics of each MS patient
| Diagnosis | Sex | EDSS | Age (years) | Disease Duration (years) | Medication |
|---|---|---|---|---|---|
| RRMS | Female | 3.0 | 38 | 6 | Beta interferon |
| RRMS | Female | 2.0 | 44 | 4 | Glatiramer acetate |
| RRMS | Female | 3.5 | 23 | 8 | Beta interferon |
| RRMS | Female | 3.0 | 46 | 19 | Beta interferon |
| RRMS | Female | 2.0 | 28 | 4 | Beta interferon |
| SPMS | Female | 6.5 | 39 | 21 | Glatiramer acetate |
| SPMS | Female | 8.0 | 64 | 20 | None |
| SPMS | Female | 8.0 | 53 | 24 | Beta interferon |
| SPMS | Female | 6.5 | 46 | 14 | Beta interferon |
| SPMS | Male | 4.0 | 42 | 18 | Beta interferon |
Note.—EDSS, Expanded Disability Status Scale; RRMS, relapsing-remitting multiple sclerosis; SPMS, secondary progressive multiple sclerosis.